Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew E Simor

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2006
Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonizationAndrew E Simor, Elizabeth Phillips, Allison McGeer, et al.
Infection Control and Hospital Epidemiology|November 10, 2005
Clinical and epidemiologic features of methicillin-resistant Staphylococcus aureus in elderly hospitalized patientsAndrew E Simor, Marianna Ofner-Agostini, Shirley Paton, et al.
Journal of Clinical Microbiology|July 8, 2005
Sensitivity and specificity of a rapid rRNA gene probe assay for simultaneous identification of Staphylococcus aureus and detection of mecAShannon Kaplan, Elizabeth M Marlowe, James J Hogan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2006
Glucose homeostasis abnormalities and gatifloxacinSandra A N Tailor, Andrew E Simor, William Cornish, et al.
Infection Control and Hospital Epidemiology|February 28, 2007
Risk factors associated with resistance to ciprofloxacin in clinical bacterial isolates from intensive care unit patientsPhillip D Levin, Robert A Fowler, Cameron Guest, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?Irfan A Dhalla, Muhammad M Mamdani, Andrew E Simor, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2004
Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitalsMichael R Mulvey, Elizabeth Bryce, David Boyd, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
Infective endocarditis of a native aortic valve due to <i>Pseudomonas aeruginosa</i> complicated by progressive multi-drug resistanceKhuloud Aldhaheri, Nisha Andany, Alireza Eshaghi, et al.
JAMA Internal Medicine|April 30, 2019
Association of Increased Colony-Count Threshold for Urinary Pathogens in Hospitalized Patients With Antimicrobial TreatmentMarc-Andre Smith, Robert Puckrin, Philip W Lam, et al.
The Journal of Antimicrobial Chemotherapy|October 27, 2007
Evaluation of Fourier transform infrared spectroscopy for the rapid identification of glycopeptide-intermediate Staphylococcus aureusNassim M Amiali, Michael R Mulvey, Brigitte Berger-Bächi, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2006
Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonizationAndrew E Simor, Elizabeth Phillips, Allison McGeer, et al.
Infection Control and Hospital Epidemiology|November 10, 2005
Clinical and epidemiologic features of methicillin-resistant Staphylococcus aureus in elderly hospitalized patientsAndrew E Simor, Marianna Ofner-Agostini, Shirley Paton, et al.
Journal of Clinical Microbiology|July 8, 2005
Sensitivity and specificity of a rapid rRNA gene probe assay for simultaneous identification of Staphylococcus aureus and detection of mecAShannon Kaplan, Elizabeth M Marlowe, James J Hogan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2006
Glucose homeostasis abnormalities and gatifloxacinSandra A N Tailor, Andrew E Simor, William Cornish, et al.
Infection Control and Hospital Epidemiology|February 28, 2007
Risk factors associated with resistance to ciprofloxacin in clinical bacterial isolates from intensive care unit patientsPhillip D Levin, Robert A Fowler, Cameron Guest, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?Irfan A Dhalla, Muhammad M Mamdani, Andrew E Simor, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2004
Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitalsMichael R Mulvey, Elizabeth Bryce, David Boyd, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
Infective endocarditis of a native aortic valve due to <i>Pseudomonas aeruginosa</i> complicated by progressive multi-drug resistanceKhuloud Aldhaheri, Nisha Andany, Alireza Eshaghi, et al.
JAMA Internal Medicine|April 30, 2019
Association of Increased Colony-Count Threshold for Urinary Pathogens in Hospitalized Patients With Antimicrobial TreatmentMarc-Andre Smith, Robert Puckrin, Philip W Lam, et al.
The Journal of Antimicrobial Chemotherapy|October 27, 2007
Evaluation of Fourier transform infrared spectroscopy for the rapid identification of glycopeptide-intermediate Staphylococcus aureusNassim M Amiali, Michael R Mulvey, Brigitte Berger-Bächi, et al.
Pageof 12